Caliper and Agilent Introduce Cell Assays for 2100 Bioanalyzer

09-Oct-2001

Caliper Technologies Corp. and Agilent Technologies Inc. announce the introduction of a kit to perform cell analysis assays on the Agilent 2100 Bioanalyzer. Jointly developed by Caliper and Agilent, the new Cell fluorescence LabChip® kit is intended for use by biochemists, molecular biologists, and cell biologists, and is designed to provide the benefits of high data quality, automation, ease of use and benchtop access to perform a range of cell cytometric analyses. The Cell Fluorescence LabChip® kit runs on a new version of the Agilent 2100 Bioanalyzer with the enhanced capability to drive fluid movement through channels of the chip by pressure or vacuum, in addition to the electrokinetic movement used in the original 2100 Bioanalyzer. A Cell Assay Extension cartridge is available for the new version of the Agilent 2100 Bioanalyzer to run the vacuum-driven cell assays. With the addition of the new kit for cell assays, the Agilent 2100 Bioanalyzer provides researchers with a convenient, efficient, single analytical platform for performing DNA, RNA, protein and cellular analyses.

The new kit performs a range of common cell analyses, including apoptosis analyses, surface and intercellular protein expression determination and viability assays. The small instrument footprint of the 2100, ease of use and low cell consumption should make flow cytometric analysis more accessible to researchers today who must rely on core facilities or manual techniques to perform routine cell analyses.

``We believe that the new Cell Fluorescence LabChip® kit will significantly enhance the utility and commercial value of the 2100 Bioanalyzer and expand the customer base for Caliper's LabChip® products,'' said Dan Kisner, M.D., Caliper's President and Chief Executive Officer. ``The ability to perform cell analyses represents a meaningful advance in lab-on-a-chip experimentation, adding direct control of hydrodynamic flow to the 2100 Bioanalyzer's repertoire of capabilities. Not only can researchers perform nucleic acid, protein and cellular assays on a single, integrated platform, but they don't even have to leave their lab bench to run these important experiments.''

The Agilent 2100 Bioanalyzer is commercialized by Agilent Technologies. The new Cell Fluorescence LabChip® kit, including chips and reagents, is priced at $515, and the Cell Assay Extension that is compatible with the new version of the 2100 Bioanalyzer is priced at $11,300. Agilent anticipates that shipping will begin in late October.

https://www.chemeurope.com/en/news/5254/caliper-and-agilent-introduce-cell-assays-for-2100-bioanalyzer.html